Observational study of medical marijuana as a treatment for treatment‐resistant epilepsies

OBJECTIVES: Medical cannabis formulations with cannabidiol (CBD) and delta‐9‐tetrahydrocannabinol (THC) are widely used to treat epilepsy. We studied the safety and efficacy of two formulations. METHODS: We prospectively observed 29 subjects (12 to 46 years old) with treatment‐resistant epilepsies (...

Descripción completa

Detalles Bibliográficos
Autores principales: Devinsky, Orrin, Marmanillo, Angelica, Hamlin, Theresa, Wilken, Philip, Ryan, Daniel, Anderson, Conor, Friedman, Daniel, Todd, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994986/
https://www.ncbi.nlm.nih.gov/pubmed/35267245
http://dx.doi.org/10.1002/acn3.51537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994986/
https://www.ncbi.nlm.nih.gov/pubmed/35267245
http://dx.doi.org/10.1002/acn3.51537

Ejemplares similares